State of the Nation
Sandy Shtab, VP of Industry and State Affairs, shares policy perspectives
This edition of RxInformer continues to monitor evolving trends in workers’ comp, from the increasing utilization of GLP-1 drugs, to drug shortages and their impact on claims, and how early pharmacy activity can signal claim risks
Sandy Shtab, VP of Industry and State Affairs, shares policy perspectives
Rising GLP-1 use is slowly creeping into claims, requiring a review of clinical considerations
Drug shortages are no longer just a pharmacy issue but a growing claims management risk in workers’ compensation, contributing to more complex claims, delayed care, and higher costs.
As part of our continuing Social Determinants of Health (SDoH) series, we examine how low health literacy can delay recovery, increase costs, and worsen claim outcomes.
Pharmacy activity in the earliest stages of a workers’ compensation claim can serve as a measurable signal of elevated risk for future complexity, cost, and duration.
